Results 31 to 40 of about 39,839 (224)

Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy [PDF]

open access: yes, 2017
BACKGROUND. Actinic keratosis is a precursor to cutaneous squamous cell carcinoma. Long treatment durations and severe side effects have limited the efficacy of current actinic keratosis treatments.
Ahu Turkoz   +18 more
core   +2 more sources

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma

open access: yesThoracic Cancer, 2023
Background Thymic squamous cell carcinoma and type B3 thymoma are primary neoplasms of the anterior mediastinum that are sometimes difficult to differentiate from one another histologically.
Koichiro Kanamori   +19 more
doaj   +1 more source

Multiple inflammatory cytokine-productive ThyL-6 cell line established from a patient with thymic carcinoma [PDF]

open access: yes, 2008
Thymic epithelial cells can produce many kinds of cytokines, and interleukin (IL)-6-producing thymic carcinoma cases have been reported. However, a cytokine-producing human thymic tumor cell line has not previously been established.
59698   +15 more
core   +1 more source

Diagnosis of Thymic Clear Cell Carcinoma by Cytology

open access: yesCase Reports in Pathology, 2013
Clear cell carcinoma of the thymus is a rare tumor. Few cases of clear-cell carcinoma of thymus have been documented (Truong et al., 1990 and Wolfe III et al., 1983).
Seema A. Lale   +2 more
doaj   +1 more source

Total thymectomy for thymic lymphoepithelioma-like carcinoma—report of two cases

open access: yesSurgical Case Reports, 2019
Background Thymic carcinoma has been classified into 12 subtypes, thymic lymphoepithelioma-like carcinoma (LELC) is a type of them, and has a pathological organization similar to that of lymphoepithelioma, an undifferentiated type of nasopharyngeal ...
Sachi Kawagishi   +8 more
doaj   +1 more source

Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma

open access: yesThoracic Cancer, 2023
Thymic carcinoma is a highly malignant tumor and treatment options are limited. Lenvatinib, a novel multitargeted kinase inhibitor, has recently been approved for the treatment of unresectable thymic carcinoma.
Masatoshi Shimura   +10 more
doaj   +1 more source

Adjuvant Therapy for Thymic Carcinoma--A Decade of Experience in a Taiwan National Teaching Hospital. [PDF]

open access: yesPLoS ONE, 2016
Thymic carcinomas are rare tumors for which surgical resection is the first treatment of choice. The role of adjuvant treatment after surgery is unknown because of limited available data.
Yen-Han Tseng   +8 more
doaj   +1 more source

Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report

open access: yesThoracic Cancer, 2022
Advanced thymic carcinomas have limited treatment options. Recently, lenvatinib was approved for advanced thymic carcinoma treatment. However, the clinical benefit of lenvatinib re‐administration in patients with advanced thymic carcinoma who developed ...
Yuto Terashima   +3 more
doaj   +1 more source

Notch and NF-kB: Coach and Players of Regulatory T-Cell Resposnse in Cancer [PDF]

open access: yes, 2018
The Notch signaling pathway plays multiple roles in driving T-cell fate decisions, proliferation, and aberrant growth. NF-kB is a cell-context key player interconnected with Notch signaling either in physiological or in pathological conditions.
Bellavia, Diana   +5 more
core   +2 more sources

Thymic Carcinoma Associated with Cerebellar Degeneration [PDF]

open access: yes, 2017
We present the case of a 57-year-old man with ataxia and clinical and radiological features of cerebellar degeneration. A computed tomography showed a mediastinal mass. The patient was diagnosed of thymic carcinoma. paraneoplastic cerebellar degeneration
García Cuartero, Irene   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy